Patents by Inventor Peter S. McFetridge

Peter S. McFetridge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11911278
    Abstract: In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein, embodiments of the present disclosure, in one aspect, relate to TMJ implantation materials and implants (e.g., temporomandibular joint (TMJ) disc), methods of making TMJ implantation materials and implants, methods of forming a TMJ implantation material or an implant, and the like.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: February 27, 2024
    Assignee: University of Florida Research Foundation, Inc.
    Inventor: Peter S. McFetridge
  • Publication number: 20220243171
    Abstract: Described herein are systems and methods relating to three-dimensional (3D) cell manufacturing utilizing a 3D growth media. According to aspects of the present disclosure, pluralities of cells and ECM components can be printed into a bioreactor as a sheet. Sheets can be retrieved, digested, split, and re-printed, thereby expanding the number of cells in an efficient manner that conserves space in a tissue culture incubator, conserves bioreactor consumables, and consumes nutrients required for cell maintenance and growth.
    Type: Application
    Filed: July 1, 2020
    Publication date: August 4, 2022
    Inventors: Thomas Ettor ANGELINI, Cameron D MORLEY, Christopher S. O'BRYAN, Peter S. MCFETRIDGE, Malisa SARNTINORANONT, Tanmay P. LELE, Naohiro Terada
  • Publication number: 20210369630
    Abstract: The present disclosure includes composite microparticles for magnetically triggered release of a biologically active agent. Also included are systems including the biocompatible composite microparticles and an alternating current (AC) magnetic field generator to magnetically trigger release of a biologically active agent from the microparticles. The present disclosure further includes methods of delivering a biologically active agent to a patient in vivo using the microparticles and systems of the present disclosure. The present disclosure also includes methods of making biocompatible composite microparticles of the present disclosure for magnetically triggered release of a biologically active agent.
    Type: Application
    Filed: October 17, 2019
    Publication date: December 2, 2021
    Inventors: Jon P. Dobson, Peter S. McFetridge, Olivia Lanier
  • Publication number: 20210007850
    Abstract: In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein, embodiments of the present disclosure, in one aspect, relate to TMJ implantation materials and implants (e.g., temporomandibular joint (TMJ) disc), methods of making TMJ implantation materials and implants, methods of forming a TMJ implantation material or an implant, and the like.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 14, 2021
    Inventor: Peter S. McFetridge
  • Patent number: 10828165
    Abstract: In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein, embodiments of the present disclosure, in one aspect, relate to TMJ implantation materials and implants (e.g., temporomandi bular joint (TMJ) methods of making TMJ implantation materials and implants, methods of forming a TMJ implantation material or an implant, and the like.
    Type: Grant
    Filed: December 7, 2012
    Date of Patent: November 10, 2020
    Assignee: University of Florida Research Foundation, Incorporated
    Inventor: Peter S. McFetridge
  • Patent number: 10300091
    Abstract: The present disclosure provides compositions including a human placental extract and biodegradable microparticles, sustained release angiogenesis-modulating compositions, compositions and methods for releasing a placental extract to a target over a period of time, and methods for inducing and/or modulating angiogenesis and identifying modulators of angiogenesis. The present disclosure also provides methods of making a composition, including a placental extract that can induce and/or modulate angiogenesis.
    Type: Grant
    Filed: May 7, 2015
    Date of Patent: May 28, 2019
    Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Peter S. McFetridge, Marc C. Moore
  • Patent number: 9821013
    Abstract: The present disclosure provides methods and compositions, including a placental extract, for inducing and/or modulating angiogenesis; methods of identifying modulators of angiogenesis, and assays for identifying modulators of angiogenesis. The present disclosure also provides methods of making a composition, including a placental extract that can induce and/or modulate angiogenesis.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: November 21, 2017
    Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Peter S. McFetridge, Marc C. Moore
  • Publication number: 20170209497
    Abstract: The present disclosure provides compositions including a human placental extract and biodegradable microparticles, sustained release angiogenesis-modulating compositions, compositions and methods for releasing a placental extract to a target over a period of time, and methods for inducing and/or modulating angiogenesis and identifying modulators of angiogenesis. The present disclosure also provides methods of making a composition, including a placental extract that can induce and/or modulate angiogenesis.
    Type: Application
    Filed: May 7, 2015
    Publication date: July 27, 2017
    Inventors: PETER S. MCFETRIDGE, MARC C. MOORE
  • Patent number: 9599604
    Abstract: In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein, embodiments of the present disclosure, in one aspect, relate to a device (or “flow chamber”), methods of making a device, methods of using a device, and the like.
    Type: Grant
    Filed: December 7, 2012
    Date of Patent: March 21, 2017
    Assignee: University of Florida Research Foundation, Incorporated
    Inventor: Peter S. McFetridge
  • Publication number: 20140364952
    Abstract: In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein, embodiments of the present disclosure, in one aspect, relate to TMJ implantation materials and implants (e.g., temporomandi bular joint (TMJ) methods of making TMJ implantation materials and implants, methods of forming a TMJ implantation material or an implant, and the like.
    Type: Application
    Filed: December 7, 2012
    Publication date: December 11, 2014
    Inventor: Peter S. McFetridge
  • Publication number: 20140294780
    Abstract: The present disclosure provides methods and compositions, including a placental extract, for inducing and/or modulating angiogenesis; methods of identifying modulators of angiogenesis, and assays for identifying modulators of angiogenesis. The present disclosure also provides methods of making a composition, including a placental extract that can induce and/or modulate angiogenesis.
    Type: Application
    Filed: April 2, 2014
    Publication date: October 2, 2014
    Inventor: Peter S. McFetridge
  • Publication number: 20140287451
    Abstract: In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein, embodiments of the present disclosure, in one aspect, relate to a device (or “flow chamber”), methods of making a device, methods of using a device, and the like.
    Type: Application
    Filed: December 7, 2012
    Publication date: September 25, 2014
    Applicant: University of Florida Research Foundation, Incorporated
    Inventor: Peter S. McFetridge
  • Patent number: 7775965
    Abstract: A tissue graft is disclosed that includes a decellularized umbilical vessel having a luminal surface and an ablumenal surface, wherein the decellularized umbilical vessel is prepared by an automated dissection process. The decellularized umbilical vessel has not been substantially cross-linked. In one method of use, the decellularized umbilical vessel is capable of having at least one cell type seeded at least a portion of at least one of the luminal and ablumenal surfaces thereof. A process of preparing the tissue graft, methods of using the tissue graft, and kits which contain the tissue graft are also disclosed.
    Type: Grant
    Filed: March 9, 2005
    Date of Patent: August 17, 2010
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: Peter S. McFetridge